American Journal of Neuroradiology, Vol 16, Issue 7 1481-1491, Copyright © 1995 by American Society of Neuroradiology
ARTICLES |
The evolution of multiple sclerosis lesions on serial MR
CR Guttmann, SS Ahn, L Hsu, R Kikinis and FA Jolesz
Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA.
PURPOSE: To characterize temporal changes in signal intensity patterns of multiple sclerosis lesions on serial MR. METHODS: T1-, T2-, proton density-, and contrast-enhanced T1-weighted MR was performed on five patients with relapsing-remitting multiple sclerosis at least 22 times in the course of 1 year. RESULTS: Forty-three enhancing lesions and 1 new lesion that never showed enhancement were detected and followed for periods ranging from approximately 4 weeks to 1 year (total of 702 time points). At first detection the center of new lesions was brighter than the periphery (20 of 24 new lesions on proton density-weighted and 19 of 23 new lesions on contrast-enhanced images). On contrast-enhanced images, ring hyperintensity was predominant at time points later than 29 days. As lesions aged, a residual rim of "nonenhancing" hyperintensity often was noted on contrast-enhanced images. Some older lesions (> 1 year) showed similar appearance on unenhanced T1-weighted images. On proton density-weighted images ring hyperintensity was most frequent 2 to 4 months after lesion detection. The estimated average duration of gadopentetate dimeglumine enhancement was 1 to 2 months. CONCLUSIONS: A lesion evolution pattern relevant to MR was inferred. We believe that specific information about the histopathologic evolution of a lesion may be extracted not only from contrast-enhanced but also from nonenhanced serial MR. Assessment of drugs targeting specific phases of lesion evolution could benefit from quantitative pattern analysis of routine MR images.
This article has been cited by other articles:
 |
|
 |
|
  L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis Brain, March 1, 2008; 131(3): 808 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Janardhan, S. Suri, and R. Bakshi Multiple Sclerosis: Hyperintense Lesions in the Brain on Nonenhanced T1-weighted MR Images Evidenced as Areas of T1 Shortening Radiology, September 1, 2007; 244(3): 823 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ge Multiple Sclerosis: The Role of MR Imaging AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1165 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ge, R. I. Grossman, J. S. Babb, J. He, and L. J. Mannon Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cotton, H. L. Weiner, F. A. Jolesz, and C. R.G. Guttmann MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals Neurology, February 25, 2003; 60(4): 640 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Morgen, N O Jeffries, R Stone, R Martin, N D Richert, J A Frank, and H F McFarland Ring-enhancement in multiple sclerosis: marker of disease severity Multiple Sclerosis, June 1, 2001; 7(3): 167 - 167. [Abstract] [PDF]
|
|
|
|
|
|
J. He, R. I. Grossman, Y. Ge, and L. J. Mannon Enhancing Patterns in Multiple Sclerosis: Evolution and Persistence AJNR Am. J. Neuroradiol., April 1, 2001; 22(4): 664 - 669. [Abstract] [Full Text]
|
|
|
|
|
|
R. I. Grossman BRAIN IMAGING AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 9 - 18. [Full Text] [PDF]
|
|
|
|
|
|
A. L. Tievsky, T. Ptak, and J. Farkas Investigation of Apparent Diffusion Coefficient and Diffusion Tensor Anisotropy in Acute and Chronic Multiple Sclerosis Lesions AJNR Am. J. Neuroradiol., September 1, 1999; 20(8): 1491 - 1499. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Khoury and H. L. Weiner Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies? Arch Intern Med, March 23, 1998; 158(6): 565 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Filippi, F. Barkhof, S. Bressi, T. Yousry, and D. Miller Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis Multiple Sclerosis, August 1, 1997; 3(4): 226 - 230. [Abstract] [PDF]
|
|